Time-of-Day Immunochemotherapy: Randomized Phase 3 Trial
Daniel Ahn
Share Talk
nature.com
to learn more
February 9, 2026
24 min
Default user image
Log in Sign Up
Channels
DiscoveryCardiology
Every Day
COVID
Every Day
Dermatology
Every DayDerms on Drugs
Endocrinology
Every DayENDO 2022ATA 2022
Gastroenterology
Every DayIBS
Hematology
Every DayCLLIMF Patient & FamilyMiracles For MyelomaASH 2024
Hepatology
Every Day
Nephrology
Every DayCKDASN 2024NKF SCM 22Kidney Week 2022
Neurology
GSA 2025
Oncology
Every DayClinical TrialseBCGastrointestinalHER2+ @ ASCO 2025ESMO 2022
Ophthalmology
Every DayAMDDry Eye DiseaseEyeCan: A Canadian Lens on OphthalmologyARVO 2024VISIONS 2024AAO 2023WIO 2022
Primary Care
Every Day
Pulmonology
Every Day
Rheumatology
Every DayHIVACR 2024
Urology
Every Day
Speaker

Description

Time-of-Day Immunochemotherapy: Randomized Phase 3 Trial
Talk's display image
Time-of-Day Immunochemotherapy: Randomized Phase 3 Trial